Page last updated: 2024-11-02

oxidopamine and Apraxia

oxidopamine has been researched along with Apraxia in 1 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Research Excerpts

ExcerptRelevanceReference
"Since this "axial apraxia' is not ameliorated by L-DOPA therapy, it has been concluded that dopamine (DA) does not play a role in recruiting axial rotation of the body [14]."1.29Spatio-temporal impairments in limb and body movements during righting in an hemiparkinsonian rat analogue: relevance to axial apraxia in humans. ( Martens, DJ; Miklyaeva, EI; Pellis, SM; Whishaw, IQ, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Martens, DJ1
Whishaw, IQ1
Miklyaeva, EI1
Pellis, SM1

Other Studies

1 other study available for oxidopamine and Apraxia

ArticleYear
Spatio-temporal impairments in limb and body movements during righting in an hemiparkinsonian rat analogue: relevance to axial apraxia in humans.
    Brain research, 1996, Sep-16, Volume: 733, Issue:2

    Topics: Animals; Apraxias; Disease Models, Animal; Dopamine; Female; Hindlimb; Humans; Motor Activity; Movem

1996